SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 307 filers reported holding SEATTLE GENETICS INC in Q4 2018. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $7,052,000 | +84.7% | 41,500 | +25.4% | 0.20% | +47.5% |
| Q1 2020 | $3,819,000 | +64.7% | 33,100 | +63.1% | 0.14% | +110.6% |
| Q4 2019 | $2,319,000 | +92.6% | 20,300 | +44.0% | 0.07% | +83.3% |
| Q3 2019 | $1,204,000 | +12.9% | 14,100 | -8.4% | 0.04% | +16.1% |
| Q2 2019 | $1,066,000 | +6.3% | 15,400 | +12.4% | 0.03% | +6.9% |
| Q1 2019 | $1,003,000 | +120.4% | 13,700 | +132.2% | 0.03% | +141.7% |
| Q3 2018 | $455,000 | -52.3% | 5,900 | -67.6% | 0.01% | -52.0% |
| Q1 2018 | $953,000 | +335.2% | 18,200 | +343.9% | 0.02% | +400.0% |
| Q4 2017 | $219,000 | -1.8% | 4,100 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $223,000 | +5.2% | 4,100 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $212,000 | – | 4,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 44,100,294 | $2,381,857,000 | 21.61% |
| Lagoda Investment Management, L.P. | 567,057 | $30,627,000 | 9.21% |
| Redmile Group, LLC | 1,781,470 | $96,217,000 | 7.65% |
| Boxer Capital, LLC | 232,600 | $12,563,000 | 5.63% |
| NEXTHERA CAPITAL LP | 111,500 | $6,022,000 | 3.70% |
| Eventide Asset Management | 835,506 | $45,126,000 | 2.76% |
| WASATCH ADVISORS LP | 2,844,908 | $153,653,000 | 2.29% |
| Opus Point Partners Management, LLC | 67,953 | $3,670,000 | 2.06% |
| CORRADO ADVISORS, LLC | 43,050 | $2,325,000 | 1.48% |
| Baillie Gifford | 16,795,793 | $907,142,000 | 1.42% |